Skip to main navigation Skip to search Skip to main content

Impact of the U.S. Food and Drug Administration's Safety Communication on Gabapentinoid-Opioid Coprescription

  • Periklis Giannakis
  • , Alex Illescas
  • , Lisa Reisinger
  • , Haoyan Zhong
  • , Crispiana Cozowicz
  • , Lazaros Poultsides
  • , Jiabin Liu
  • , Jashvant Poeran
  • , Stavros G. Memtsoudis

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)775-778
Number of pages4
JournalAnesthesiology
Volume143
Issue number3
DOIs
StatePublished - 1 Sep 2025
Externally publishedYes

Cite this